Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond.

Tytuł:
Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond.
Autorzy:
Perl J; Division of Nephrology, St. Michael's Hospital and the Keenan Research Center in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Fuller DS; Arbor Research Collaborative for Health, Ann Arbor, Michigan.
Boudville N; Medical School, University of Western Australia, Perth, Australia.
Kliger AS; Section of Nephrology, Department of Internal Medicine, Yale School of Medicine and Yale New Haven Health System, New Haven, Connecticut.
Schaubel DE; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
Teitelbaum I; Division of Kidney Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.
Warady BA; Division of Nephrology, Children's Mercy Kansas City, Kansas City, Missouri.
Neu AM; Division of Pediatric Nephrology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Patel PR; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Piraino B; Department of Medicine, Renal Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania.
Schreiber M; Home Modalities, DaVita Kidney Care, Denver, Colorado.
Pisoni RL; Arbor Research Collaborative for Health, Ann Arbor, Michigan.
Źródło:
Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2020 Dec 31; Vol. 16 (1), pp. 154-161. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
Język:
English
Imprint Name(s):
Publication: 2023- : Hagerstown, MD : Wolters Kluwer Health
Original Publication: Washington, D.C. : American Society of Nephrology, c2005-
MeSH Terms:
Quality Improvement*
Data Collection/*standards
Peritoneal Dialysis/*adverse effects
Peritoneal Dialysis/*standards
Peritonitis/*etiology
Peritonitis/*prevention & control
Humans ; Peritonitis/microbiology ; Practice Guidelines as Topic ; Renal Dialysis/standards ; Terminology as Topic ; United States
References:
Australia and New Zealand Dialysis and Transplant Registry: Chapter 5: Peritoneal Dialysis. In: 41st Report, 2018. Available at: https://www.anzdata.org.au/report/anzdata-41st-annual-report-2018-anzdata/ . Accessed January 11, 2019.
Kolesnyk I, Dekker FW, Boeschoten EW, Krediet RT: Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int 30: 170–177, 2010 20124193.
Mujais S, Story K: Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts. Kidney Int Suppl 70: S21–S26, 2006 17080107.
Davies SJ, Bryan J, Phillips L, Russell GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 498–506, 1996 8671821.
Mehrotra R, Devuyst O, Davies SJ, Johnson DW: The current state of peritoneal dialysis. J Am Soc Nephrol 27: 3238–3252, 2016 27339663.
Manera KE, Johnson DW, Craig JC, Shen JI, Ruiz L, Wang AY, Yip T, Fung SKS, Tong M, Lee A, Cho Y, Viecelli AK, Sautenet B, Teixeira-Pinto A, Brown EA, Brunier G, Dong J, Dunning T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wilkie M, Tong A: Patient and caregiver priorities for outcomes in peritoneal dialysis: Multinational nominal group technique study. Clin J Am Soc Nephrol 14: 74–83, 2019 30573659.
Qamar M, Sheth H, Bender FH, Piraino B: Clinical outcomes in peritoneal dialysis: Impact of continuous quality provement initiatives. Adv Perit Dial 25: 76–79, 2009 19886322.
Bender FH, Bernardini J, Piraino B: Prevention of infectious complications in peritoneal dialysis: Best demonstrated practices. Kidney Int Suppl 103: S44–S54, 2006 17080111.
Boudville N, Johnson DW, Zhao J, Bieber BA, Pisoni RL, Piraino B, Bernardini J, Nessim SJ, Ito Y, Woodrow G, Brown F, Collins J, Kanjanabuch T, Szeto CC, Perl J: Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 34: 2118–2126, 2019 30053214.
United States Renal Data System: 2018 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018.
Weiner D, Watnick S: The ESRD quality incentive program-Can we bridge the chasm? J Am Soc Nephrol 28: 1697–1706, 2017 28298324.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW: ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36: 481–508, 2016 27282851.
Al Sahlawi M, Wilson G, Tallard B, Manera KE, Tong A, Pisoni RL, Fuller DS, Cho Y, Johnson DW, Piraino B, Schreiber MJ, Boudville NC, Teitelbaum I, Perl J: Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int 40: 132–140, 2020.
DOPPS: The Peritoneal Dialysis Outcomes and Practice Patterns Study. Available at: https://www.dopps.org/OurStudies/PeritonealDialysisPDOPPS.aspx . Accessed May 11, 2020.
Ma TK, Chow KM, Kwan BC, Pang WF, Leung CB, Li PK, Szeto CC: Peritonitis before peritoneal dialysis training: Analysis of causative organisms, clinical outcomes, risk factors, and long-term consequences. Clin J Am Soc Nephrol 11: 1219–1226, 2016 27269302.
Balzer MS, Claus R, Haller H, Hiss M: Are ISPD guidelines on peritonitis diagnosis too narrow? A 15-year retrospective single-center cohort study on PD-associated peritonitis accounting for untrained patients. Perit Dial Int 39: 220–228, 2019 30846609.
Centers for Disease Control and Prevention: Dialysis Event Surveillance Protocol, February 2018. Available at: https://www.cdc.gov/nhsn/PDFs/pscManual/8pscDialysisEventcurrent.pdf . Accessed August 15, 2019.
Centers for Medicare and Medicaid Services: Dialysis Facility Reports, 2017. Available at: https://data.cms.gov/download/ub2a-kzvr/application%2Fzip . Accessed September 13, 2019.
United States Renal Data System: 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2016.
Centers for Disease Control and Prevention (CDC): Reduction in central line-associated bloodstream infections among patients in intensive care units--Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 54: 1013–1016, 2005 16224448.
Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355: 2725–2732, 2006 17192537.
Nguyen DB, Shugart A, Lines C, Shah AB, Edwards J, Pollock D, Sievert D, Patel PR: National Healthcare Safety Network (NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol 12: 1139–1146, 2017 28663227.
George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH: Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: Prospective study. BMJ 332: 1435, 2006 16777887.
Patel PR, Yi SH, Booth S, Bren V, Downham G, Hess S, Kelley K, Lincoln M, Morrissette K, Lindberg C, Jernigan JA, Kallen AJ: Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report. Am J Kidney Dis 62: 322–330, 2013 23676763.
Centers for Disease Control and Prevention (CDC): Reducing bloodstream infections in an outpatient hemodialysis center--New Jersey, 2008-2011. MMWR Morb Mortal Wkly Rep 61: 169–173, 2012 22419049.
Yi SH, Kallen AJ, Hess S, Bren VR, Lincoln ME, Downham G, Kelley K, Booth SL, Weirich H, Shugart A, Lines C, Melville A, Jernigan JA, Kleinbaum DG, Patel PR: Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort. Infect Control Hosp Epidemiol 37: 863–866, 2016 26868605.
Mudge DW, Boudville N, Brown F, Clayton P, Duddington M, Holt S, Johnson DW, Jose M, Saweirs W, Sud K, Voss D, Walker R: Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action. Nephrology (Carlton) 21: 535–546, 2016 26807739.
Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM: Peritoneal dialysis practice in Australia and New Zealand: A call to action. Nephrology (Carlton) 16: 19–29, 2011 21175973.
Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group. Perit Dial Int 9: 159–163, 1989 2488361.
Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticelli C: Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2: 642–644, 1983 6136794.
Lindholm T, Simonsen O, Krutzen L, van Leusen R, Jordans JGM, Mooy JMV, Diderich PP, Sbornik M, Montassine MC, Brouard R, Allouache M, Rottembourg J: Evaluation of a new take-off system: A prospective randomized multicenter study. Adv Perit Dial 6: 264–265, 1988.
Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, Salcedo RM, García E, Matos M, Kaji J, Vázquez R, Ramos A, Schettino MA, Moran J; The Mexican Nephrology Collaborative Study Group: Prevention of peritonitis with disconnect systems in CAPD: A randomized controlled trial. Kidney Int 54: 2123–2128, 1998 9853278.
Bordin G, Casati M, Sicolo N, Zuccherato N, Eduati V: Patient education in peritoneal dialysis: An observational study in Italy. J Ren Care 33: 165–171, 2007 18298034.
Hall G, Bogan A, Dreis S, Duffy A, Greene S, Kelley K, Lizak H, Nabut J, Schinker V, Schwartz N: New directions in peritoneal dialysis patient training. Nephrol Nurs J 31: 149–154, 159–163, 2004.
Figueiredo AE, Moraes TP, Bernardini J, Poli-de-Figueiredo CE, Barretti P, Olandoski M, Pecoits-Filho R; BRAZPD Investigators: Impact of patient training patterns on peritonitis rates in a large national cohort study. Nephrol Dial Transplant 30: 137–142, 2015 25204318.
Bernardini J, Price V, Figueiredo A; International Society for Peritoneal Dialysis (ISPD) Nursing Liaison Committee: Peritoneal dialysis patient training, 2006. Perit Dial Int 26: 625–632, 2006 17047225.
Chen TW, Li SY, Chen JY, Yang WC: Training of peritoneal dialysis patients—Taiwan’s experiences. Perit Dial Int 28[Suppl 3]: S72–S75, 2008 18552269.
Chow KM, Szeto CC, Law MC, Fun Fung JS, Kam-Tao Li P: Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol 2: 647–652, 2007 17699477.
Figueiredo AE, Bernardini J, Bowes E, Hiramatsu M, Price V, Su C, Walker R, Brunier G: A syllabus for teaching peritoneal dialysis to patients and caregivers. Perit Dial Int 36: 592–605, 2016 26917664.
Chow JSF, Cho Y, Equinox KL, Figueiredo A, Frasca S, Hawley C, Howard K, Johnson DW, Jose M, Lee A, Maley M, Moodie JA, Brent PA, Pascoe E, Reidinger D, Steiner GZ, Tomlins M, Voss D, Woodward P, Boudville N: An intervention design: Supporting skills development for peritoneal dialysis trainers. Perit Dial Int 39: 134–141, 2019 30661004.
Auguste BL, Girsberger M, Kennedy C, Srithongkul T, McGrath-Chong M, Bargman J, Chan CT: Are adverse events in newly trained home dialysis patients related to learning styles? A single-centre retrospective study from Toronto, Canada. BMJ Open 10: e033315, 2020.
Mujais S: Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 70: S55–S62, 2006 17080112.
Yip T, Tse KC, Lam MF, Cheng SW, Lui SL, Tang S, Ng M, Chan TM, Lai KN, Lo WK: Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 27: 560–564, 2007 17704448.
Neu AM, Miller MR, Stuart J, Lawlor J, Richardson T, Martz K, Rosenberg C, Newland J, McAfee N, Begin B, Warady BA; SCOPE Collaborative Participants: Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol 29: 1477–1484, 2014 25055994.
Children’s Hospital Association: SCOPE Dialysis Collaborative, 2019. Available at: https://www.childrenshospitals.org/Programs-and-Services/Quality-Improvement-and-Measurement/Collaboratives/SCOPE . Accessed August 1, 2019.
Neu AM, Richardson T, Lawlor J, Stuart J, Newland J, McAfee N, Warady BA; SCOPE Collaborative Participants: Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney Int 89: 1346–1354, 2016 27165827.
Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F: Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 32[Suppl 2]: S32–S86, 2012 22851742.
Kliger AS, Collins AJ: Long overdue need to reduce infections with hemodialysis. Clin J Am Soc Nephrol 12: 1728–1729, 2017 28974522.
NephSAP: Infection control and prevention in outpatient hemodialysis facilities. NephSAP 18: 1–7, 2019.
Grant Information:
R01 HS025756 United States HS AHRQ HHS
Contributed Indexing:
Keywords: Health Care Costs; Incidence; Peritonitis; Quality Improvement; Translational Medical Research; dialysis; dialysis-associated peritonitis; peritoneal dialysis
Entry Date(s):
Date Created: 20200809 Date Completed: 20211206 Latest Revision: 20230424
Update Code:
20240105
PubMed Central ID:
PMC7792655
DOI:
10.2215/CJN.11280919
PMID:
32764025
Czasopismo naukowe
Peritoneal dialysis (PD)-associated peritonitis is the leading cause of permanent transition to hemodialysis among patients receiving PD. Peritonitis is associated with higher mortality risk and added treatment costs and limits more widespread PD utilization. Optimizing the prevention of peritonitis in the United States will first require standardization of peritonitis definitions, key data elements, and outcomes in an effort to facilitate nationwide reporting. Standardized reporting can also help describe the variability in peritonitis rates and outcomes across facilities in the United States in an effort to identify potential peritonitis prevention strategies and engage with stakeholders to develop strategies for their implementation. Here, we will highlight considerations and challenges in developing standardized definitions and implementation of national reporting of peritonitis rates by PD facilities. We will describe existing peritonitis prevention evidence gaps, highlight successful infection-reporting initiatives among patients receiving in-center hemodialysis or PD, and provide an overview of nationwide quality improvement initiatives, both in the United States and elsewhere, that have translated into a reduction in peritonitis incidence. We will discuss opportunities for collaboration and expansion of the Nephrologists Transforming Dialysis Safety (NTDS) initiative to develop knowledge translation pathways that will lead to dissemination of best practices in an effort to reduce peritonitis incidence.
(Copyright © 2021 by the American Society of Nephrology.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies